Recently, the Ministry of Health issued Circular 30/2023/TT-BYT, delineating 50 disease categories and health conditions eligible for remote diagnosis and treatment. Covering nearly 20 medical specialties, this list includes conditions such as obesity, acute and chronic pharyngitis, tonsillitis, neck and shoulder pain, carpal tunnel syndrome, lower back pain, inflammatory joint diseases, spinal degeneration, cancer survivorship, chronic diseases (hypertension, diabetes, lipid disorders, thyroid disorders, non-dialysis chronic kidney disease), neurology and psychiatry disorders (anxiety, depression, mental disorders, tension headaches, vestibular disorders, migraine, Alzheimer’s, Parkinson’s), infectious diseases (dengue fever without warning signs, influenza, COVID-19, HIV/AIDS), dermatology conditions (viral, allergic, immune, bacterial, and fungal-parasitic skin diseases), as well as other specialties like ophthalmology, functional rehabilitation, digestive, and respiratory systems.

Effective from January 1, 2024, under the Health Examination and Treatment Law 2023, remote diagnosis and treatment involve medical practitioners providing healthcare services through devices and information technology without direct contact with patients. Practitioners must adhere to professional standards, follow the specified list of diseases, and take responsibility for diagnostic results, treatment processes, and medication prescriptions.

The ministry aims to continuously update the list based on deployment experience, patient needs, and healthcare facility requirements in the future. The telemedicine project, launched by the Ministry of Health in 2020, seeks to provide accessible medical counseling, remote diagnosis, and expert support from local to central healthcare levels, ensuring quality healthcare services for everyone at grassroots healthcare establishments.